HONG KONG--(BUSINESS WIRE)--Aug. 17, 2006--American Oriental Bioengineering Inc. (AMEX: AOB), a leading Chinese manufacturer and distributor of plant-based pharmaceutical and nutraceutical products, today announced that Lily Li, the company’s operations officer and acting CFO, will present at the Roth Capital Partners New York Conference on Sept. 6 at the Westin New York in Times Square Manhattan. Accompanying her will be the VP of finance, Wilfred Chow. The company’s presentation is scheduled for 2 p.m. Eastern and will include an interactive question and answer session. Following the presentation, Li and Chow will be available for one-on-one meetings with analysts and investors, interested parties should contact their Roth Capital representative.
